Back

Mortality and heart failure benefits of sglt2 inhibitors in transthyretin amyloid cardiomyopathy: a cohort and integrated meta-analysis

11 May 2026 (11:04 - 12:21)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - epidemiology, prognosis, outcome (3) Epidemiology, Prognosis, Outcome Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Barbara Lage Garcia

Alto Ave Hospital Center, Guimaraes (Portugal)

6 More presentations in this session

Presentation thumbnail
NT-proBNP in patients with symptomatic peripheral artery disease
Mr D. Kosuta (Ljubljana, SI)
Abstract Slides
Presentation thumbnail
Comparison of clinical characteristics according to body mass index categories in patients with heart failure
Associate Professor S. Murat (Eskisehir, TR)
Abstract Slides
Presentation thumbnail
Patients hospitalized for heart failure who lack access to a specialized heart failure management program: an especially vulnerable population
Doctor S. Ruiz Bustillo (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Prognostic value of fractures in hospitalized patients with heart failure: insights from the JROADHF-NEXT registry
Doctor Y. Singh (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Effectiveness of sodium-glucose co-transporter 2 inhibitors in stroke prevention among patients with heart failure: a propensity-score matched cohort study
Mr J. Tang (Hong Kong, HK)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - epidemiology, prognosis, outcome (3)

The Event

Event poster

Heart Failure 2026

11 May 2026 11:04 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources